Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

CompletedOBSERVATIONAL
Enrollment

275

Participants

Timeline

Start Date

November 24, 2022

Primary Completion Date

April 5, 2024

Study Completion Date

April 5, 2024

Conditions
Primary Immune Thrombocytopenia (ITP)
Trial Locations (17)

Unknown

Hôpital Universitaire Henri Mondor, Créteil

CHU Dijon - Hôpital François Mitterrand Médecine 1 - Etudes Cliniques, Dijon

CHU Toulouse - Hôtel-Dieu Saint-Jacques, Toulouse

Careggi Hospital, Florence

Fondazione Policlinico A. Gemelli IRCCS, Roma

San Bortolo Hospital, Vicenza, Vicenza

Bergen Hospital, Bergen

Oslo Hospital, Oslo

Østfold Hospital, Oslo

Hospital del Mar, Barcelona, Barcelona

Hospital General Universitario de Burgos, Burgos

Hospital Morales Meseguer, Murcia

Basel university hospital, Basel

Bern university hospital, Bern

Lausanne University hospital, Lausanne

Imperial College NHS Trust, London

University Hospitals Plymouth NHS Trust, Plymouth

All Listed Sponsors
collaborator

Fondazione Progetto Ematologia

OTHER

lead

European Research Consortium on ITP

OTHER